Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP928590.RAnm5AH4nwUL65I3xwmlfW6eQVrK757FrEvyWyaU3P_ho130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP928590.RAnm5AH4nwUL65I3xwmlfW6eQVrK757FrEvyWyaU3P_ho130_assertion type Assertion NP928590.RAnm5AH4nwUL65I3xwmlfW6eQVrK757FrEvyWyaU3P_ho130_head.
- NP928590.RAnm5AH4nwUL65I3xwmlfW6eQVrK757FrEvyWyaU3P_ho130_assertion wasGeneratedBy ECO_0000203 NP928590.RAnm5AH4nwUL65I3xwmlfW6eQVrK757FrEvyWyaU3P_ho130_provenance.
- NP928590.RAnm5AH4nwUL65I3xwmlfW6eQVrK757FrEvyWyaU3P_ho130_assertion wasDerivedFrom befree-20150227 NP928590.RAnm5AH4nwUL65I3xwmlfW6eQVrK757FrEvyWyaU3P_ho130_provenance.
- NP928590.RAnm5AH4nwUL65I3xwmlfW6eQVrK757FrEvyWyaU3P_ho130_assertion SIO_000772 17852451 NP928590.RAnm5AH4nwUL65I3xwmlfW6eQVrK757FrEvyWyaU3P_ho130_provenance.
- NP928590.RAnm5AH4nwUL65I3xwmlfW6eQVrK757FrEvyWyaU3P_ho130_assertion evidence source_evidence_literature NP928590.RAnm5AH4nwUL65I3xwmlfW6eQVrK757FrEvyWyaU3P_ho130_provenance.
- NP928590.RAnm5AH4nwUL65I3xwmlfW6eQVrK757FrEvyWyaU3P_ho130_assertion description "[Increased PRV-1 expression was found in 37 out of 46 patients diagnosed with PV (80%), in 4 out of 15 patients diagnosed with essential thrombocythemia (ET) (27%) and in 4 out of 8 patients with chronic idiopathic myelofibrosis (CIMF) (50%), and increased PRV-1 expression plus EEC formation was observed in 19 of 36 examined MPD patients indicating the superiority of PVSG and WHO bone marrow criteria for the diagnosis of ET, PV and CIMF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP928590.RAnm5AH4nwUL65I3xwmlfW6eQVrK757FrEvyWyaU3P_ho130_provenance.